- Country: Ukraine
- Summary: Indirab Anti-Rabia Vaccine Purified, Inactivated Lyophilized Powder for Solution for Injection at Least 2.5 Iu/Dose and Solvent #1
- UAT Ref No: 131172929
- Deadline: 04 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 49300
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINIndirab Anti-Rabia Vaccine Purified, Inactivated Lyophilized Powder for Solution for Injection at Least 2.5 Iu/Dose and Solvent #1 - Ukraine Tender
The MUNICIPAL NON-COMMERCIAL ENTERPRISE "KREMENETSK SUPPORT HOSPITAL" OF THE KREMENETSK CITY COUNCIL, a Government sector organization in Ukraine, has announced a new tender for Indirab Anti-Rabia Vaccine Purified, Inactivated Lyophilized Powder for Solution for Injection at Least 2.5 Iu/Dose and Solvent #1. This tender is published on UkraineTenders under UAT Ref No: 131172929 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-04.
The estimated tender value is UAH 49300, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
